Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Rumi · SciRah

Researcher profile · Semantic Scholar

E. Rumi

Share profile

E. Rumi — researcher profile on SciRah

h-index: 67
Works: 336
Citations: 22K

Most-cited papers

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
M. Maffioli, B. Mora, S. Ball, A. Iurlo +23 more
2022Blood Advances121 citations Open access
Semantic Scholar
Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study
J. Kiladjian, P. Zachée, M. Hino, F. Pane +18 more
2020The Lancet Haematology112 citations Open access
Semantic Scholar
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.
T. Barbui, A. Vannucchi, V. De Stefano, A. Masciulli +33 more
2021The Lancet Haematology108 citations Open access
Semantic Scholar
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study
T. Barbui, A. Ghirardi, A. Masciulli, A. Carobbio +37 more
2019Leukemia88 citations Open access
Semantic Scholar
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
T. Barbui, A. Vannucchi, A. Álvarez-Larrán, A. Iurlo +47 more
2021Leukemia80 citations Open access
Semantic Scholar
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases
Emanuela Sant'Antonio, P. Guglielmelli, L. Pieri, M. Primignani +31 more
2019American journal of hematology/oncology72 citations Open access
Semantic Scholar
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients withmyeloproliferative neoplasms.
C. D. Di Buduo, V. Abbonante, C. Marty, F. Moccia +12 more
2019Blood65 citations Open access
Semantic Scholar
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study
P. Guglielmelli, A. Ghirardi, A. Carobbio, A. Masciulli +15 more
2021Blood Advances64 citations Open access
Semantic Scholar
Mutational Landscape of the Transcriptome Offers Putative Targets for Immunotherapy of Myeloproliferative Neoplasms.
Fiorella Schischlik, R. Jäger, F. Rosebrock, E. Hug +20 more
2019Blood63 citations Open access
Semantic Scholar
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
P. Guglielmelli, A. Carobbio, E. Rumi, V. De Stefano +11 more
2020Blood Cancer Journal55 citations Open access
Semantic Scholar
Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy
A. Bozzani, V. Arici, G. Tavazzi, M. Franciscone +9 more
2020Surgery52 citations Open access
Semantic Scholar
Novel Drivers and Modifiers of MPL-dependent Oncogenic Transformation Identified by Deep Mutational Scanning.
Jessica L. Bridgford, Su-Min Lee, Christine M. M. Lee, P. Guglielmelli +10 more
2019Blood51 citations
Semantic Scholar
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.
T. Barbui, A. Vannucchi, V. De Stefano, A. Carobbio +34 more
2023NEJM Evidence44 citations Open access
Semantic Scholar
A journey through infectious risk associated with ruxolitinib
Emanuela Sant'Antonio, M. Bonifacio, M. Breccia, E. Rumi
2019British Journal of Haematology36 citations
Semantic Scholar
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
C. Pecquet, Nicolas Papadopoulos, Thomas Balligand, I. Chachoua +38 more
2022Blood34 citations Open access
Semantic Scholar
Second cancers in MPN: Survival analysis from an international study
M. Marchetti, A. Ghirardi, A. Masciulli, A. Carobbio +40 more
2019American journal of hematology/oncology34 citations Open access
Semantic Scholar
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer. A case-control study.
V. De Stefano, A. Ghirardi, A. Masciulli, A. Carobbio +39 more
2019Blood33 citations Open access
Semantic Scholar
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
T. Barbui, V. De Stefano, A. Álvarez-Larrán, A. Iurlo +47 more
2021Blood Cancer Journal32 citations Open access
Semantic Scholar
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms
G. Todisco, M. Creignou, A. Gallì, P. Guglielmelli +18 more
2020Leukemia28 citations
Semantic Scholar
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis
A. Carobbio, P. Guglielmelli, E. Rumi, C. Cavalloni +8 more
2020Blood Cancer Journal28 citations Open access
Semantic Scholar
Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet.
A. Álvarez-Larrán, Emanuela Sant'Antonio, C. Harrison, J. Kiladjian +10 more
2021The Lancet Haematology25 citations
Semantic Scholar
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients.
M. Maffioli, T. Giorgino, B. Mora, A. Iurlo +24 more
2019Blood Advances25 citations Open access
Semantic Scholar
Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms
E. Rumi, S. Zibellini, E. Boveri, C. Cavalloni +10 more
2019American journal of hematology/oncology25 citations Open access
Semantic Scholar
Type 1 but not type 2 calreticulin mutations activate the IRE1a/XBP1 pathway of the unfolded protein response to drive myeloproliferative neoplasms.
Juan Ibarra, Yassmin A. Elbanna, Katarzyna Kuryłowicz, Michele Ciboddo +24 more
2022Blood Cancer Discovery24 citations Open access
Semantic Scholar
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
T. Barbui, A. Carobbio, Juergen Thiele, N. Gangat +21 more
2023Blood Cancer Journal23 citations Open access
Semantic Scholar
The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance
E. Rumi, C. Trotti, D. Vanni, I. Casetti +2 more
2020International Journal of Molecular Sciences22 citations Open access
Semantic Scholar
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes
T. Barbui, A. Carobbio, V. De Stefano, A. Álvarez-Larrán +37 more
2023Annals of Hematology21 citations Open access
Semantic Scholar
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
B. Mora, E. Rumi, P. Guglielmelli, D. Barraco +22 more
2019Cancer Medicine21 citations Open access
Semantic Scholar
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients
B. Mora, P. Guglielmelli, A. Kuykendall, E. Rumi +29 more
2022Leukemia19 citations Open access
Semantic Scholar
PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
J. D. Milosevic Feenstra, R. Jäger, Fiorella Schischlik, Daniel Ivanov +13 more
2022American journal of hematology/oncology19 citations Open access
Semantic Scholar
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs
J. Jutzi, A. Marneth, Michele Ciboddo, A. Guerra-Moreno +13 more
2022Blood18 citations Open access
Semantic Scholar
Myeloproliferative and lymphoproliferative disorders: State of the art
E. Rumi, C. Baratè, G. Benevolo, M. Maffioli +2 more
2019Hematological Oncology17 citations
Semantic Scholar
Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
A. Carobbio, A. Vannucchi, E. Rumi, V. De Stefano +9 more
2023Blood Cancer Journal16 citations Open access
Semantic Scholar
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice
M. Breccia, C. Baratè, G. Benevolo, M. Bonifacio +13 more
2019Annals of Hematology15 citations Open access
Semantic Scholar
Facing erythrocytosis: Results of an international physician survey
E. Rumi, M. McMullin, C. Harrison, M. Ellis +11 more
2019American journal of hematology/oncology15 citations Open access
Semantic Scholar
A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Advanced Myelofibrosis (MF): Updated Results and Genomic Analyses
K. Pettit, H. Gill, A. Yacoub, T. Bradley +28 more
2022Blood14 citations Open access
Semantic Scholar
Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation.
G. Rotunno, C. Mannarelli, Giada Brogi, Annalisa Pacilli +12 more
2019Blood14 citations Open access
Semantic Scholar
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project
G. Coltro, Emanuela Sant'Antonio, G. Palumbo, F. Mannelli +17 more
2023Cancer Medicine13 citations Open access
Semantic Scholar
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
T. Barbui, A. Ghirardi, A. Carobbio, A. Masciulli +19 more
2022Blood Cancer Journal13 citations Open access
Semantic Scholar
Long-term follow-up of recovered MPN patients with COVID-19
T. Barbui, A. Iurlo, A. Masciulli, A. Carobbio +48 more
2021Blood Cancer Journal13 citations Open access
Semantic Scholar
JAK inhibitors and risk of B-cell lymphomas.
E. Rumi, S. Zibellini
2019Blood13 citations
Semantic Scholar
Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group
B. Mora, P. Guglielmelli, E. Rumi, M. Maffioli +26 more
2019American journal of hematology/oncology13 citations Open access
Semantic Scholar
Immunogenicity and clinical efficacy of anti‐SARS‐CoV‐2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients
M. Salvini, C. Damonte, L. Mortara, F. Maggi +20 more
2022American journal of hematology/oncology12 citations Open access
Semantic Scholar
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis.
S. Rontauroli, S. Castellano, P. Guglielmelli, R. Zini +28 more
2021Blood Advances12 citations Open access
Semantic Scholar
Incidence of blast phase in myelofibrosis according to anemia severity
B. Mora, M. Maffioli, E. Rumi, P. Guglielmelli +21 more
2023eJHaem11 citations Open access
Semantic Scholar
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.
Barbara Mora, F. Palandri, Paola Guglielmelli, Andrew T. Kuykendall +34 more
2026Blood10 citations Open access
Semantic Scholar
Platelet count predicts driver mutations’ co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis
B. Mora, Claudia Siracusa, E. Rumi, M. Maffioli +16 more
2020Leukemia10 citations
Semantic Scholar
Arginase‐1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver
A. Bonometti, O. Borsani, E. Rumi, V. Ferretti +4 more
2022Cancer Medicine9 citations Open access
Semantic Scholar
P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENTS WITH ADVANCED MYELOFIBROSIS
H. Gill, A. Yacoub, K. Pettit, T. Bradley +32 more
2022HemaSphere9 citations Open access
Semantic Scholar
Acute deep vein thrombosis in COVID 19 hospitalized patients. Risk factors and clinical outcomes
A. Bozzani, G. Tavazzi, V. Arici, A. Sterpetti +4 more
2020Phlebology9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Vannucchi×29
Invite
A. Vannucchi — researcher profile on SciRah
P. Guglielmelli×24
Invite
P. Guglielmelli — researcher profile on SciRah
T. Barbui×20
Invite
T. Barbui — researcher profile on SciRah
V. De Stefano×19
Invite
V. De Stefano — researcher profile on SciRah

×18

Invite

F. Palandri — researcher profile on SciRah

Invite

A. Iurlo — researcher profile on SciRah

A. Carobbio×16

Invite

A. Carobbio — researcher profile on SciRah

F. Passamonti×15

Invite

F. Passamonti — researcher profile on SciRah

G. Benevolo×15

Invite

G. Benevolo — researcher profile on SciRah

Invite

B. Mora — researcher profile on SciRah

Invite

S. Betti — researcher profile on SciRah

A. Rambaldi×13

Invite

A. Rambaldi — researcher profile on SciRah